SavedAdd your journal

Journals / Turkish Journal of Gastroenterology / 2018 / Cilt: 29 - Sayı: 6

The evaluation of the effect of Helicobacter pylori infection on choroidal thickness

Cemile ÜÇGÜL ATILGAN
Ahmet YOZGAT
Pınar KÖSEKAHYA
MEHTAP ÇAĞLAYAN
Selam Yekta ŞENDÜL
Nilüfer BERKER
Zeynep ALTIPARMAK
Emin ALTIPARMAK
Pelin YILMAZBAŞ
Pages
636–641
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Eradication of H. pylori infection appears tohave produced no change in short-term CT.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: To evaluate the effects of Helicobacter pylori infection on choroidal thickness (CT) using enhanced depth imagingspectral domain-optical coherence tomography (SD-OCT).Materials and Methods: A total of 63 right eyes of 63 patients who tested positive for H. pylori (Group 1) and 46 right eyes of 46 patients who tested negative for H. pylori (Group 2) were evaluated.
📊
Key Findings & Data:The CTs at the subfoveal area and at 1 mm ranging up to 3 mm fromthe fovea at the nasal and temporal quadrants were measured and compared.
💡
Conclusion & Impact:Eradication of H. pylori infection appears tohave produced no change in short-term CT.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: To evaluate the effects of Helicobacter pylori infection on choroidal thickness (CT) using enhanced depth imagingspectral domain-optical coherence tomography (SD-OCT).Materials and Methods: A total of 63 right eyes of 63 patients who tested positive for H. pylori (Group 1) and 46 right eyes of 46 patients who tested negative for H. pylori (Group 2) were evaluated. The CTs at the subfoveal area and at 1 mm ranging up to 3 mm fromthe fovea at the nasal and temporal quadrants were measured and compared. After the eradication of H. pylori, the CT values were alsocompared with the pre-eradication values in 38 patients.Results: The mean age of patients was 43.6±9.5 years in Group 1 and 46.6±11.5 years in Group 2 (p=0.13). Differences in CT values between Groups 1 and 2 before and after H. pylori eradication were not statistically significant (p>0.05 for all values).Conclusion: The CT values of H. pylori positive and H. pylori negative patients were similar. Eradication of H. pylori infection appears tohave produced no change in short-term CT.

🔖

Cite This Article

ATILGAN, C. Ü., YOZGAT, A., KÖSEKAHYA, P., ÇAĞLAYAN, M., ŞENDÜL, S. Y., BERKER, N., ALTIPARMAK, Z., ALTIPARMAK, E., YILMAZBAŞ, P. (2018). The evaluation of the effect of Helicobacter pylori infection on choroidal thickness. Turkish Journal of Gastroenterology, Cilt: 29 - Sayı: 6, 636–641. https://ajindex.com/articles/410127

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Ozaydın N, Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the C-Urea breath test. BMC Public Health 2013; 13: 1215. [CrossRef] De Koster E, De Bruyne I, Langlet P, Deltenre M. Evidence based medicine and extradigestive manifestation of Helicobacter Pylori. Acta Gastroenterol Belg 2000; 63: 388-92. Zbinden R. Expanding the spectrum of Helicobacter pylori-associated diseases. Infection 2005; 33: 49. [CrossRef] Saccà SC, Pascotto A, Venturino GM, et al. Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci 2006; 47: 501-8. [CrossRef] Izzotti A, Saccà SC, Bagnis A, Recupero SM. Glaucoma and Helicobacter pylori infection: correlations and controversies. Br J Ophthalmol 2009; 93: 1420-7. [CrossRef] Mauget- Faysse M, Kodjikiann L, et al. Role de I’ Helicobacter pylori dans la chorioretinopathie sereuse centrale et I’epitheliopathie retinienne diffuse. (Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study). J Fr Ophthalmol 2002; 25: 1021-5. Yanuzzi LA. Type A behaviour and central serous chorioretinopathy. Trans Am Ophthalmol Soc 1986: 84; 799-845.
  2. Ahnoux-Zabsonre A, Quaranta M, Mauget-Faÿsse M. Prevalence of Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy: a complementary study. J Fr Ophtalmol 2004; 27: 1129-33. [CrossRef] Giusti C. Central serous chorioretinopathy: a new extragastric manifestation of Helicobacter pylori: Analysis of a clinical case. Clin Ter 2001; 152: 393-7.
  3. Rahbani-Nobar MB, Javadzadeh A, Ghojazadeh L, Rafeey M, Ghorbanihaghjo A. The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy. Mol Vis 2011; 17: 99-103.
  4. Zavoloka O, Bezditko P, Lahorzhevska I, Zubkova D, Ilyina Y. Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy. Graefes Arrch Clin Exp Ophthalmol 2016; 254: 1737-42. [CrossRef] Aceti A, Are R, Sabino G, et al. Helicobacter pylori active infection in patients with acute coronary heart disease. J Infect 2004; 49: 8-12. [CrossRef] Andreica V, Sandica-Andreica B, Draghici A, Chiorean E, Georoceanu A, Rusu M. The prevalence of anti-Helicobacter pylori antibodies in the patients with ischemic heart diseases. Rom J Inter Med 2004; 42: 183-9. Sheehan